Whitefort Capital Management, LP
CIK: 1884931
Holdings (19)
Q2 2026 13F, quarter ended Jun 30, 2026, filed Aug 14, 2026
- ABUS
ARBUTUS BIOPHARMA CORP
$75.81M
15.79M sh18.69%+5.8% - ROIV
ROIVANT SCIENCES LTD
$36.06M
1.02M sh8.89%-28.2% - JOYY
JOYY INC
$34.64M
524,944 sh8.54%+0.0% - BALY
BALLYS CORPORATION
$33.01M
2.41M sh8.14%+0.0% - GNW
GENWORTH FINL INC
$29.64M
3.13M sh7.31%+0.0% - NN
NEXTNAV INC
$28.46M
1.60M sh7.01%+2531.5% - OABI
OMNIAB INC
$25.21M
10.25M sh6.21%-27.9% - ZD
ZIFF DAVIS INC
$21.91M
418,389 sh5.40%New - TDAY
USA TODAY CO INC
$17.14M
2.00M sh4.23%-35.8% - CDZI
CADIZ INC
$16.66M
3.99M sh4.11%+0.0% - SGRY
SURGERY PARTNERS INC
$15.14M
901,332 sh3.73%-1.1% - PUBM
PUBMATIC INC
$14.57M
1.11M sh3.59%+61.0% - OPKO HEALTH INC
OPKO HEALTH INC
$14.07M
9.35M sh3.47%+0.0% - VATE
INNOVATE CORP
$13.87M
743,000 sh3.42%+0.0% - SOC
SABLE OFFSHORE CORP
$11.46M
3.72M sh2.82%+140.8% - OPK
OPKO HEALTH INC
$6.77M
4.51M sh1.67%+6.1% - DDI
DOUBLEDOWN INTERACTIVE CO LT
$6.27M
546,172 sh1.55%New - TEAD
TEADS HLDG CO
$3.53M
4.61M sh0.87%+27.7% - KG
KESTREL GROUP LTD
$1.45M
160,916 sh0.36%+0.0%
| Security | Shares | Value | Change | Weight | Period |
|---|---|---|---|---|---|
 ABUS ARBUTUS BIOPHARMA CORP | 15.79M | $75.81M | +5.8% | 18.69% | Q2 2026 |
 ROIV ROIVANT SCIENCES LTD | 1.02M | $36.06M | -28.2% | 8.89% | Q2 2026 |
 JOYY JOYY INC | 524,944 | $34.64M | +0.0% | 8.54% | Q2 2026 |
 BALY BALLYS CORPORATION | 2.41M | $33.01M | +0.0% | 8.14% | Q2 2026 |
 GNW GENWORTH FINL INC | 3.13M | $29.64M | +0.0% | 7.31% | Q2 2026 |
 NN NEXTNAV INC | 1.60M | $28.46M | +2531.5% | 7.01% | Q2 2026 |
 OABI OMNIAB INC | 10.25M | $25.21M | -27.9% | 6.21% | Q2 2026 |
 ZD ZIFF DAVIS INC | 418,389 | $21.91M | New | 5.40% | Q2 2026 |
 TDAY USA TODAY CO INC | 2.00M | $17.14M | -35.8% | 4.23% | Q2 2026 |
 CDZI CADIZ INC | 3.99M | $16.66M | +0.0% | 4.11% | Q2 2026 |
 SGRY SURGERY PARTNERS INC | 901,332 | $15.14M | -1.1% | 3.73% | Q2 2026 |
 PUBM PUBMATIC INC | 1.11M | $14.57M | +61.0% | 3.59% | Q2 2026 |
OPKO HEALTH INC OPKO HEALTH INC | 9.35M | $14.07M | +0.0% | 3.47% | Q2 2026 |
 VATE INNOVATE CORP | 743,000 | $13.87M | +0.0% | 3.42% | Q2 2026 |
 SOC SABLE OFFSHORE CORP | 3.72M | $11.46M | +140.8% | 2.82% | Q2 2026 |
 OPK OPKO HEALTH INC | 4.51M | $6.77M | +6.1% | 1.67% | Q2 2026 |
 DDI DOUBLEDOWN INTERACTIVE CO LT | 546,172 | $6.27M | New | 1.55% | Q2 2026 |
 TEAD TEADS HLDG CO | 4.61M | $3.53M | +27.7% | 0.87% | Q2 2026 |
 KG KESTREL GROUP LTD | 160,916 | $1.45M | +0.0% | 0.36% | Q2 2026 |
1-19 of 19 holdings
Sector Allocation
SEC Filings
| Form | Description | Filed |
|---|---|---|
About Whitefort Capital Management, LP
Whitefort Capital Management, LP is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 1884931). Signal8 holds 20 13F filings from it. Its SEC filings list Delaware as its state of incorporation.
Its most recent 13F holdings report covers Q2 2026 (the quarter ended Jun 30, 2026) and was filed on Aug 14, 2026. That report lists 19 securities, not counting options, the same number as in Q1 2026.
Its five largest reported positions, in order, are ARBUTUS BIOPHARMA CORP (ABUS), ROIVANT SCIENCES LTD (ROIV), JOYY INC (JOYY), BALLYS CORPORATION (BALY) and GENWORTH FINL INC (GNW). The next five are NEXTNAV INC (NN), OMNIAB INC (OABI), ZIFF DAVIS INC (ZD), USA TODAY CO INC (TDAY) and CADIZ INC (CDZI).
Recent 13F filings by Whitefort Capital Management, LP
- Q2 2026: 13F-HR filed Aug 14, 2026, listing 19 securities.
- Q1 2026: 13F-HR filed May 15, 2026, listing 19 securities.
- Q4 2025: 13F-HR filed Feb 17, 2026, listing 17 securities.
- Q3 2025: 13F-HR filed Nov 14, 2025, listing 16 securities.
- Q2 2025: 13F-HR/A filed Nov 12, 2025, listing 17 securities.
- Q2 2025: 13F-HR filed Aug 14, 2025, listing 17 securities.